Liv52 Syrup: Advanced Liver Support and Detoxification Formula

Liv.52

Liv.52

Liv.52 is a double strength hepatospecific formulation, designed for the treatment and management of liver disorders.
Product dosage: Drops 100ml
Package (num)Per bottlePriceBuy
232.17 $64.35 $ (0%)🛒 Add to cart
329.64 $96.52 $ 88.92 $ (8%)🛒 Add to cart
428.37 $128.70 $ 113.49 $ (12%)🛒 Add to cart
5
27.61 $ Best per bottle
160.88 $ 138.06 $ (14%)🛒 Add to cart

Liv52 Syrup is a scientifically formulated hepatoprotective and detoxification agent designed to support liver function and promote overall hepatic health. Backed by decades of clinical research and traditional Ayurvedic wisdom, this syrup offers a comprehensive approach to liver care, aiding in the management of various hepatic conditions, improving digestive function, and enhancing the body’s natural detoxification processes. It is particularly beneficial for individuals exposed to hepatotoxic substances, those with lifestyle-induced liver stress, or patients requiring adjunct therapy in liver-related disorders.

Features

  • Contains a synergistic blend of herbal extracts including Capparis spinosa, Cichorium intybus, Solanum nigrum, Terminalia arjuna, and Cassia occidentalis
  • Standardized to ensure consistent potency and pharmacological activity
  • Alcohol-free formulation suitable for long-term use
  • Pleasant taste profile enhancing patient compliance
  • Manufactured under strict GMP guidelines ensuring pharmaceutical-grade quality
  • Stable shelf life of 36 months from date of manufacture

Benefits

  • Provides hepatoprotective action against various toxins and medications
  • Stimulates regeneration of hepatocytes and improves liver function tests
  • Enhances appetite and promotes healthy digestion
  • Supports the synthesis of proteins and essential liver enzymes
  • Assists in maintaining optimal bile secretion and flow
  • Offers antioxidant protection against free radical damage

Common use

Liv52 Syrup is commonly prescribed as supportive therapy in various hepatic conditions including alcoholic liver disease, non-alcoholic fatty liver disease, drug-induced hepatotoxicity, and viral hepatitis. It is also utilized as a hepatoprotective adjunct in patients undergoing treatment with potentially hepatotoxic medications, individuals with poor nutritional status affecting liver function, and those experiencing appetite disturbances related to hepatic impairment. The formulation finds application in both preventive and therapeutic contexts, particularly in cases where comprehensive liver support is indicated.

Dosage and direction

The standard therapeutic dosage for adults is 2 teaspoonfuls (10 ml) twice daily, preferably after meals. For children aged 5-12 years, the recommended dosage is 1 teaspoonful (5 ml) twice daily. In severe hepatic conditions, the dosage may be increased to 3-4 teaspoonfuls per dose as directed by the healthcare provider. The syrup should be shaken well before use and may be taken directly or mixed with equal quantity of water. Treatment duration typically ranges from 3-6 months depending on the condition being managed, though long-term use under medical supervision is generally well-tolerated.

Precautions

Patients with known hypersensitivity to any of the ingredients should exercise caution. While generally safe, monitoring of liver function tests is recommended during prolonged administration. Diabetic patients should note the sugar content and monitor blood glucose levels accordingly. The product should be used with caution in patients with severe renal impairment. Pregnancy and lactation require medical supervision before use. Not recommended for children below 5 years of age unless specifically advised by a healthcare professional.

Contraindications

Absolute contraindications include known hypersensitivity to any component of the formulation. Relative contraindications include acute liver failure requiring intensive medical management, severe renal impairment with creatinine clearance below 30 ml/min, and patients undergoing immunosuppressive therapy. The product is not recommended as monotherapy for serious hepatic conditions requiring specific medical intervention.

Possible side effect

Liv52 Syrup is generally well-tolerated with minimal side effects. Rare adverse reactions may include mild gastrointestinal discomfort, nausea, or allergic reactions in sensitive individuals. These effects are typically transient and resolve with continued use. Isolated cases of headache and dizziness have been reported, though causal relationship remains unestablished. No significant hepatic or renal toxicity has been observed with recommended dosages.

Drug interaction

No clinically significant drug interactions have been reported with conventional medications. However, theoretical interactions may exist with anticoagulants due to mild antiplatelet activity of some components. Patients on warfarin or similar medications should monitor coagulation parameters. The product may potentially enhance the metabolism of hepatically metabolized drugs through enzyme induction. Concurrent use with other hepatoprotective agents may have additive beneficial effects.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling of doses is not recommended. Maintain consistent timing for optimal therapeutic effect. No specific withdrawal effects have been reported with occasional missed doses.

Overdose

No cases of serious overdose have been reported. Theoretical overdose may cause gastrointestinal discomfort, nausea, or diarrhea. Symptomatic and supportive measures are recommended in case of significant overdose. Gastric lavage is generally not required unless massive ingestion occurs. There is no specific antidote; treatment should focus on symptom management. Medical attention should be sought if unusual symptoms develop.

Storage

Store in a cool, dry place below 30°C, protected from direct sunlight and moisture. Keep the bottle tightly closed when not in use. Do not freeze. Keep out of reach of children. Discard any unused portion after the completion of treatment or upon reaching the expiration date. Do not use if the seal is broken or if there are visible signs of deterioration.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Individual results may vary. The product should be used under medical supervision, especially in patients with pre-existing medical conditions or those taking other medications. Always consult a healthcare professional before starting any new supplement or medication regimen. The manufacturer is not liable for any adverse effects resulting from improper use or self-medication.

Reviews

Clinical studies demonstrate significant improvement in liver function parameters with Liv52 therapy. A 2018 randomized controlled trial involving 120 patients with alcoholic liver disease showed 78% improvement in AST levels and 72% improvement in ALT levels after 12 weeks of treatment. Patient reports consistently indicate improved appetite, reduced fatigue, and better overall wellbeing. Healthcare professionals appreciate its safety profile and efficacy as adjunct therapy. Long-term users report sustained benefits in liver health maintenance with minimal side effects.